SWA
IMUX icon

Strategies Wealth Advisors’s Immunic IMUX Stock Holding History

Strategies Wealth Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Hold
10,000
– – 0.01% 197
2026
Q1 		$111K Hold
10,000
– – 0.01% 188
2025
Q4 		$53.4K Hold
10,000
– – 0.01% 184
2025
Q3 		$88.2K Hold
10,000
– – 0.01% 183
2025
Q2 		$69.8K Buy
+10,000
New +$91.8K 0.01% 182

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Strategies Wealth Advisors's IMUX Position: Q2 2026 in Review

Strategies Wealth Advisors held its Immunic (IMUX) position steady in Q2 2026 at 10,000 shares worth $154K. The position accounts for 0.01% of the portfolio, ranked #197.

Strategies Wealth Advisors first reported a position in IMUX in Q2 2025 and has held it in 5 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Strategies Wealth Advisors held 10,000 shares of Immunic worth $154K as of Q2 2026.
  • Strategies Wealth Advisors left its Immunic share count unchanged in Q2 2026.
  • Immunic made up 0.01% of Strategies Wealth Advisors's portfolio in Q2 2026, its #197 holding.
  • Strategies Wealth Advisors first reported a position in Immunic in Q2 2025 and has held it in 5 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Strategies Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.